Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Terminated × Carcinoma in Situ × Interferons × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Genitourinary 1

Conditions

Neoplasms 3 Carcinoma, Renal Cell 3 Virus Diseases 1 Urinary Bladder Neoplasms 1 Sarcoma 1 Melanoma 1 Carcinoma, Transitional Cell 1 Carcinoma in Situ 1 Adenoviridae Infections 1

Interventions

valrubicin 2 Gemcitabine 2 enfortumab vedotin 1 durvalumab 1 advexin 1 Surveys and Questionnaires 1 Standard of Care 1 Oncolytic Virotherapy 1 Nivolumab 1 Mitomycin 1 Interferons 1 Cystoscopy 1 Biopsy 1 ALT-801 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT01438112 2021-04-14

BOND

CG Oncology, Inc.

Phase 2/3 Terminated

Adenoviridae Infections, Urinary Bladder Neoplasms, Carcinoma in Situ, Carcinoma, Transitional Cell, Neoplasms, Virus Diseases

Data powered by HemOnc (CC BY 4.0) Colophon ⚡